Center of Oncocytogenetics Institute of Clinical Biochemistry and Laboratory Diagnostics 1 Faculty of Medicine Charles University and General University Hospital Prague Czech Republic

CLIP Childhood Leukaemia Investigation Prague Czech Republic

Department of Haematology Sheffield Children's Hospital UK

Department of Paediatric Haematology and Oncology 2 Faculty of Medicine Charles University and University Hospital Motol Prague Czech Republic

Leukaemia Research Cytogenetics Group Northern Institute for Cancer Research Newcastle University Newcastle upon Tyne UK

Zobrazit více v PubMed

Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. Lancet. 2013;381(9881):1943–1955. PubMed PMC

Gale KB, Ford AM, Repp R, et al. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA. 1997;94(25):13950–13954. PubMed PMC

Maia AT, van der Velden VH, Harrison CJ, et al. Prenatal origin of hyperdiploid acute lymphoblastic leukemia in identical twins. Leukemia. 2003;17(11):2202–2206. PubMed

Greaves MF, Maia AT, Wiemels JL, Ford AM. Leukemia in twins: lessons in natural history. Blood. 2003;102(7):2321–2333. PubMed

Zuna J, Burjanivova T, Mejstrikova E, et al. Covert preleukemia driven by MLL gene fusion. Genes Chromosomes Cancer. 2009;48(1):98–107. PubMed

Metzler M, Staege MS, Harder L, et al. Inv(11)(q21q23) fuses MLL to the Notch co-activator mastermind-like 2 in secondary T-cell acute lymphoblastic leukemia. Leukemia. 2008;22(9):1807–1811. PubMed

Horsley SW, Colman S, McKinley M, et al. Genetic lesions in a preleukemic aplasia phase in a child with acute lymphoblastic leukemia. Genes Chromosomes Cancer. 2008;47(4):333–340. PubMed

Anderson K, Lutz C, van Delft FW, et al. Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature. 2011;469(7330):356–361. PubMed

Gehan EA, Freireich EJ. The 6-MP versus placebo clinical trial in acute leukemia. Clin Trials. 2011;8(3):288–297. PubMed

Sherwood AM, Desmarais C, Livingston RJ, et al. Deep sequencing of the human TCRgamma and TCRbeta repertoires suggests that TCRbeta rearranges after alphabeta and gammadelta T cell commitment. Sci Transl Med. 2011;3(90):90ra61. PubMed PMC

Braza MS, Klein B. Anti-tumour immunotherapy with Vgamma9Vdelta2 T lymphocytes: from the bench to the bedside. Br J Haematol. 2013;160(2):123–132. PubMed

Cummings JS, Cairo C, Armstrong C, Davis CE, Pauza CD. Impacts of HIV infection on Vgamma2Vdelta2 T cell phenotype and function: a mechanism for reduced tumor immunity in AIDS. J Leukoc Biol. 2008;84(2):371–379. PubMed PMC

Gertner-Dardenne J, Castellano R, Mamessier E, et al. Human Vgamma9Vdelta2 T cells specifically recognize and kill acute myeloid leukemic blasts. J Immunol. 2012;188(9):4701–4708. PubMed

Coscia M, Vitale C, Peola S, et al. Dysfunctional Vgamma9Vdelta2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells. Blood. 2012;120(16):3271–3279. PubMed

Fidanza M, Seif AE, DeMicco A, et al. Inhibition of precursor B-cell malignancy progression by toll-like receptor ligand-induced immune responses. Leukemia. 2016;30(10):2116–2119. PubMed PMC